Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfons Soler

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bone Marrow Transplantation|August 18, 2021
Predictors of return to work after autologous stem cell transplantation in patients with multiple myelomaMiquel Granell, Alicia Senín, Anna Barata, et al.
Hemasphere|July 8, 2024
Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world settingAdrián Alegre, Mercedes Gironella, Fernando Escalante, et al.
Blood|August 18, 2005
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMAJoan Bladé, Laura Rosiñol, Ana Sureda, et al.
Annals of Hematology|February 15, 2025
Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myelomaAntoni Garcia-Guiñon, Paola Andrea Charry, María Jimenez, et al.
Leukemia & Lymphoma|August 30, 2021
A randomized phase II study comparing consolidation with a single dose of <sup>90</sup>Y ibritumomab tiuxetan <i>vs.</i> maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up resultsArmando López-Guillermo, Miguel Ángel Canales, Ivan Dlouhy, et al.
Experimental Hematology & Oncology|December 19, 2020
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European countryAna Muntañola, Guillermo Villacampa, José Ángel Hernández-Rivas, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bone Marrow Transplantation|August 18, 2021
Predictors of return to work after autologous stem cell transplantation in patients with multiple myelomaMiquel Granell, Alicia Senín, Anna Barata, et al.
Hemasphere|July 8, 2024
Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world settingAdrián Alegre, Mercedes Gironella, Fernando Escalante, et al.
Blood|August 18, 2005
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMAJoan Bladé, Laura Rosiñol, Ana Sureda, et al.
Annals of Hematology|February 15, 2025
Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myelomaAntoni Garcia-Guiñon, Paola Andrea Charry, María Jimenez, et al.
Leukemia & Lymphoma|August 30, 2021
A randomized phase II study comparing consolidation with a single dose of <sup>90</sup>Y ibritumomab tiuxetan <i>vs.</i> maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up resultsArmando López-Guillermo, Miguel Ángel Canales, Ivan Dlouhy, et al.
Experimental Hematology & Oncology|December 19, 2020
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European countryAna Muntañola, Guillermo Villacampa, José Ángel Hernández-Rivas, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
Pageof 2